Difficulty: Medium
Average Score: 93%
Practice
A client with end-stage cancer receiving Morphine is prescribed Methylnaltrexone. The client's daughter asks why the provider prescribed Methylnaltrexone. Which of the following responses should the nurse make?
Correct answer
C
Rationale
In this scenario, the correct response is C) The medication will relieve your mother's constipation.
The rationale behind this is that Methylnaltrexone is a peripherally acting mu-opioid receptor antagonist that is specifically used to treat opioid-induced constipation without affecting the central nervous system's analgesic effects of opioids like Morphine. By blocking the mu-opioid receptors in the gut, Methylnaltrexone helps to alleviate the constipation side effect caused by opioids without interfering with the pain relief provided by Morphine.
Option A is incorrect because Methylnaltrexone does not increase respiration, as it is not centrally acting like traditional opioid antagonists such as Naloxone. Option B is incorrect because Methylnaltrexone does not prevent dependence on Morphine; its primary purpose is to address constipation. Option D is incorrect because while Methylnaltrexone does work in conjunction with Morphine, it does not directly increase pain relief but rather targets constipation.
In an educational context, it is crucial for nurses to understand the rationale for using adjunct medications like Methylnaltrexone in managing side effects of opioid therapy. This knowledge enables healthcare providers to provide comprehensive care while minimizing adverse effects for patients with conditions like end-stage cancer.
The rationale behind this is that Methylnaltrexone is a peripherally acting mu-opioid receptor antagonist that is specifically used to treat opioid-induced constipation without affecting the central nervous system's analgesic effects of opioids like Morphine. By blocking the mu-opioid receptors in the gut, Methylnaltrexone helps to alleviate the constipation side effect caused by opioids without interfering with the pain relief provided by Morphine.
Option A is incorrect because Methylnaltrexone does not increase respiration, as it is not centrally acting like traditional opioid antagonists such as Naloxone. Option B is incorrect because Methylnaltrexone does not prevent dependence on Morphine; its primary purpose is to address constipation. Option D is incorrect because while Methylnaltrexone does work in conjunction with Morphine, it does not directly increase pain relief but rather targets constipation.
In an educational context, it is crucial for nurses to understand the rationale for using adjunct medications like Methylnaltrexone in managing side effects of opioid therapy. This knowledge enables healthcare providers to provide comprehensive care while minimizing adverse effects for patients with conditions like end-stage cancer.